Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prospects for oral vaccination using recombinant bacteria expressing viral epitopes.

× No keyword cloud information.

9 in total

Review 1. Recombinant avirulent salmonellae as oral vaccine carriers.

Authors: F Schödel
Journal: Infection Date: 1992 Jan-Feb Impact factor: 3.553

2. The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice.

Authors: J Benyacoub; S Hopkins; A Potts; S Kelly; J P Kraehenbuhl; R Curtiss; P De Grandi; D Nardelli-Haefliger
Journal: Infect Immun Date: 1999-07 Impact factor: 3.441

3. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain.

Authors: D Nardelli-Haefliger; J P Kraehenbuhl; R Curtiss; F Schodel; A Potts; S Kelly; P De Grandi
Journal: Infect Immun Date: 1996-12 Impact factor: 3.441

4. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.

Authors: S Hopkins; J P Kraehenbuhl; F Schödel; A Potts; D Peterson; P de Grandi; D Nardelli-Haefliger
Journal: Infect Immun Date: 1995-09 Impact factor: 3.441

5. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.

Authors: F Schödel; S M Kelly; D L Peterson; D R Milich; R Curtiss
Journal: Infect Immun Date: 1994-05 Impact factor: 3.441

6. Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium.

Authors: David Baud; Jalil Benyacoub; Véronique Revaz; Menno Kok; Françoise Ponci; Martine Bobst; Roy Curtiss; Pierre De Grandi; Denise Nardelli-Haefliger
Journal: Infect Immun Date: 2004-02 Impact factor: 3.441

7. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.

Authors: Dominique Fraillery; David Baud; Susana Yuk-Ying Pang; John Schiller; Martine Bobst; Nathalie Zosso; Françoise Ponci; Denise Nardelli-Haefliger
Journal: Clin Vaccine Immunol Date: 2007-08-08

8. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae.

Authors: A R Nayak; S A Tinge; R C Tart; L S McDaniel; D E Briles; R Curtiss
Journal: Infect Immun Date: 1998-08 Impact factor: 3.441

9. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.

Authors: David Baud; Françoise Ponci; Martine Bobst; Pierre De Grandi; Denise Nardelli-Haefliger
Journal: J Virol Date: 2004-12 Impact factor: 5.103

9 in total